BICISATE DIHYDROCHLORIDE
BICISATE DIHYDROCHLORIDE is an active ingredient listed in 2 FDA drug label records from 2 manufacturers marketed mainly as human prescription drug products.
About BICISATE DIHYDROCHLORIDE
BICISATE DIHYDROCHLORIDE appears as the active ingredient in 2 FDA drug label records. These products are produced by 2 distinct manufacturers, with the largest catalogues from Lantheus Medical Imaging, Inc., SHINE SPECT USA, LLC. Approved labelling for these products most frequently references: indications neurolite, single photon, emission computerized, tomography spect, indicated adjunct, conventional mri, localization stroke, assessment functional. Every record below is taken from FDA Structured Product Labelling data; use it to compare brand names, strengths and manufacturers before speaking with a pharmacist.
Main manufacturers
| Manufacturer | Products | Marketing type |
|---|---|---|
| Lantheus Medical Imaging, Inc. | 1 | HUMAN PRESCRIPTION DRUG |
| SHINE SPECT USA, LLC | 1 | HUMAN PRESCRIPTION DRUG |
FDA drug products containing BICISATE DIHYDROCHLORIDE
Frequently asked questions
How many FDA drug products contain BICISATE DIHYDROCHLORIDE?
2 FDA drug label records list BICISATE DIHYDROCHLORIDE as the active ingredient, supplied by 2 manufacturers. The table below lists the brand names, manufacturers and dosage forms covered by those labels.
Which companies make BICISATE DIHYDROCHLORIDE products?
The manufacturers with the most BICISATE DIHYDROCHLORIDE label records are Lantheus Medical Imaging, Inc., SHINE SPECT USA, LLC. Generic and brand versions may be produced by different companies.
Is this a substitute for medical advice?
No. This page reproduces FDA labelling data so you can identify a product and its manufacturer. Dosing, interactions and suitability must be confirmed with a prescriber or pharmacist.
This page reproduces FDA Structured Product Labelling data for identification purposes. It is not medical advice and does not recommend, sell or price any medicine.